170 related articles for article (PubMed ID: 35571033)
1. Transcriptome-Wide Analysis of RNA N
Fang S; Peng B; Wen Y; Yang J; Wang H; Wang Z; Qian K; Wei Y; Jiao Y; Gao C; Dou L
Front Genet; 2022; 13():833694. PubMed ID: 35571033
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic Value of
LE N; Yang JJ; Liu YC; Zhang XW; Wang H; Wen YN; Jiao YF; Wang LL; Dou LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):355-364. PubMed ID: 38660836
[TBL] [Abstract][Full Text] [Related]
3. TUG1 knockdown enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant acute myeloid leukemia HL60/ADR cells.
Chen L; Zhao H; Wang C; Hu N
RSC Adv; 2019 Apr; 9(19):10897-10904. PubMed ID: 35515331
[TBL] [Abstract][Full Text] [Related]
4. Gli-1/PI3K/AKT/NF-kB pathway mediates resistance to radiation and is a target for reversion of responses in refractory acute myeloid leukemia cells.
Li X; Chen F; Zhu Q; Ding B; Zhong Q; Huang K; Jiang X; Wang Z; Yin C; Zhu Y; Li Z; Meng F
Oncotarget; 2016 May; 7(22):33004-15. PubMed ID: 27105509
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.
Zhang Y; Liu Y; Xu X
J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500
[TBL] [Abstract][Full Text] [Related]
6. In vitro anti-leukemia activity of dual PI3K/mTOR inhibitor Voxtalisib on HL60 and K562 cells, as well as their multidrug resistance counterparts HL60/ADR and K562/A02 cells.
Zhang L; Wang Z; Khishignyam T; Chen T; Zhou C; Zhang Z; Jin M; Wang R; Qiu Y; Kong D
Biomed Pharmacother; 2018 Jul; 103():1069-1078. PubMed ID: 29710665
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effect of ZSTK474 alone or in combination with chemotherapeutic drugs on HL60 and HL60/ADR cells.
Zhou Q; Chen Y; Zhang L; Zhong Y; Zhang Z; Wang R; Jin M; Gong M; Qiu Y; Kong D
Oncotarget; 2017 Jun; 8(24):39064-39076. PubMed ID: 28388564
[TBL] [Abstract][Full Text] [Related]
8. TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2.
Li Q; Song W; Wang J
Biomed Pharmacother; 2019 Jan; 109():1793-1801. PubMed ID: 30551433
[TBL] [Abstract][Full Text] [Related]
9. Dynamic alterations of the transcriptome-wide m
Zhang J; Liu T; Wang Y; Yan X; Li Y; Xu F; Zhang R
Genomics; 2023 Nov; 115(6):110725. PubMed ID: 37820824
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals RNA N6-methyladenosine modification associated with prognosis and drug resistance in acute myeloid leukemia.
Li Z; Liu X; Wang L; Zhao H; Wang S; Yu G; Wu D; Chu J; Han J
Front Immunol; 2023; 14():1281687. PubMed ID: 38022588
[TBL] [Abstract][Full Text] [Related]
11. Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia.
Ma H; Zhou H; Song X; Shi S; Zhang J; Jia L
Oncogene; 2015 Feb; 34(6):726-40. PubMed ID: 24531716
[TBL] [Abstract][Full Text] [Related]
12. HOTAIR suppresses PTEN via DNMT3b and confers drug resistance in acute myeloid leukemia.
Zhou W; Xu S; Chen X; Wang C
Hematology; 2021 Dec; 26(1):170-178. PubMed ID: 33538241
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of multidrug resistance in HL60 cells. Analysis of resistance associated membrane proteins and levels of mdr gene expression.
McGrath T; Latoud C; Arnold ST; Safa AR; Felsted RL; Center MS
Biochem Pharmacol; 1989 Oct; 38(20):3611-9. PubMed ID: 2573357
[TBL] [Abstract][Full Text] [Related]
14. METTL3-Mediated lncRNA m
Song Y; Pan Y; Wu M; Sun W; Luo L; Zhao Z; Liu J
Stem Cell Rev Rep; 2021 Dec; 17(6):2276-2290. PubMed ID: 34505967
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome-wide m
Sun W; Song Y; Xia K; Yu L; Huang X; Zhao Z; Liu J
Stem Cell Res Ther; 2021 Sep; 12(1):489. PubMed ID: 34470673
[TBL] [Abstract][Full Text] [Related]
16. The m
Sang L; Wu X; Yan T; Naren D; Liu X; Zheng X; Zhang N; Wang H; Li Y; Gong Y
J Cancer; 2022; 13(3):1019-1030. PubMed ID: 35154467
[TBL] [Abstract][Full Text] [Related]
17. TCP1 increases drug resistance in acute myeloid leukemia by suppressing autophagy via activating AKT/mTOR signaling.
Chen X; Chen X; Huang Y; Lin J; Wu Y; Chen Y
Cell Death Dis; 2021 Nov; 12(11):1058. PubMed ID: 34750375
[TBL] [Abstract][Full Text] [Related]
18. Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.
Zhang X; Hao H; Ma L; Zhang Y; Hu X; Chen Z; Liu D; Yuan J; Hu Z; Guan W
mBio; 2021 Aug; 12(4):e0106721. PubMed ID: 34225491
[TBL] [Abstract][Full Text] [Related]
19. LncRNA KCNQ1OT1 contributes to the progression and chemoresistance in acute myeloid leukemia by modulating Tspan3 through suppressing miR-193a-3p.
Sun H; Sun Y; Chen Q; Xu Z
Life Sci; 2020 Jan; 241():117161. PubMed ID: 31837329
[TBL] [Abstract][Full Text] [Related]
20. The Role of RNA Methyltransferase
Wu X; Ye W; Gong Y
Front Oncol; 2022; 12():873903. PubMed ID: 35574332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
